iBio, Inc. IBIO
0.82 USD +0.02 (+2.95%)
At closeNov 4, 2026, 8:27 AM EST
0.84 +0.02 +2.00%
Pre-market · Nov 4, 8:27 AM ET
0.7902 Day range 0.8359
0.69 52-week range 3.82
- YTD
- -57.33%
- 1 year
- -46.18%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 3.60
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 2
- 2 months ago 2
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.45 | -0.45 – -0.45 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next quarter | -0.39 | -0.39 – -0.39 | -0.97899 | +60.2% | 0 | 0.0% | 1 |
| Current year | -1.74 | -1.74 – -1.74 | -4.29 | +59.5% | 0 | -100.0% | 1 |
| Next year | -2.05 | -2.05 – -2.05 | -1.74 | -17.8% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2024 | LUCID CAPITAL MARKETS | Initiated | — | Buy |
| Jul 22, 2024 | Brookline Capital | Initiated | — | Buy |
| Jun 3, 2024 | Chardan Capital | Maintained | Buy | Buy |
| May 28, 2024 | Chardan Capital | Initiated | — | Buy |